Botanical species · safety record

Cicer arietinum

The EFSA Compendium of Botanicals holds 16 constituent measurements for Cicer arietinum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cicer arietinum L.

16Constituent measurements

0Safety records

4Cited sources

25Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 25 licensed products naming Cicer arietinum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Bean
Cicer arietinum - seed
New material
Seed(s)
Sprout(s)

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Amylase inhibitors	Seed	—	—	Unspecified	Resolve DOI
Daidzein	Seed	Solvent extraction	≤ 19 Milligram/gram	Unspecified	Resolve DOI
Daidzein	Seed	Solvent extraction	≥ 1 Milligram/gram	Unspecified	Resolve DOI
Genistein	Seed	Solvent extraction	≥ 7 Milligram/gram	Unspecified	Resolve DOI
Genistein	Seed	Solvent extraction	≤ 21 Milligram/gram	Unspecified	Resolve DOI
Lectins	Seed	—	—	Unspecified	Resolve DOI
Oxalates	Seed	—	0.07 Percent	Unspecified	Resolve DOI
Phytic acid	Seed	—	≥ 1.21 Gram/kilogram	Unspecified	Resolve DOI
Phytic acid	Seed	—	≤ 10.6 Gram/kilogram	Unspecified	Resolve DOI
Saponins	Seed	Solvent extraction	0.4 Milligram/100 gram	Unspecified	Resolve DOI
Saponins	Seed	—	0.91 Milligram/gram	Unspecified	Resolve DOI
Secoisolarisiresinol	Seed	Solvent extraction	1 Milligram/gram	Unspecified	Resolve DOI
Trypsin inhibitors	Seed	—	—	Unspecified	Resolve DOI
Cyanogenic glycosides	Seed	Solvent extraction	—	Unspecified	No resolvable identifier
Isoflavones	Fruit unspecified	Solvent extraction	—	Unspecified	No resolvable identifier
Triterpene saponins	Fruit unspecified	Solvent extraction	—	Unspecified	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Campos-Vega, Rocio., Loarca-Pina, Guadalupe., Oomah, B. Dave. Minor components of pulses and their potential impact on human health. Food research international, 2010, vol. 43, no. 2, p. 461-482. DOI
Gupta, Rinkesh Kumar., Gupta, Kriti., Sharma, Akanksha., Das, Mukul., Ansari, Irfan Ahmad., Dwivedi, Premendra D. Health Risks and Benefits of Chickpea (Cicer arietinum) Consumption. Journal of agricultural and food chemistry, 2017, vol. 65, no. 1, p. 6-22. DOI
Li, Peng-shou., Liu, Yang-yang., Fan, Bing-duo., Wei, Qian., Li, Chun-na., Xu, Tun-hai., Liu, Tong-hua. Research progress of chemical composition and pharmacological effectiveness of chickpeas. Zhongguo shiyan fangjixue zazhi, 2014, p. 235-238.
Z�llner, H., Giebelmann, R. Cyanogenic glycosides in food - Cultural historical remarks Cyanogene Glykoside in Lebensmitteln - Kulturhistorische Betrachtungen . Deutsche lebensmittel-rundschau, 2007, vol. 103, no. 2, p. 71-77.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature